SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-010142
Filing Date
2018-07-18
Accepted
2018-07-18 16:18:21
Documents
4
Period of Report
2018-07-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39812
2 ex4-1.htm EX-4.1 141989
3 ex10-1.htm EX-10.1 151494
4 ex99-1.htm EX-99.1 10973
  Complete submission text file 0001493152-18-010142.txt   345732
Mailing Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070
Business Address 201 ROUTE 17 NORTH 2ND FLOOR RUTHERFORD NJ 07070 201.528.9200
CANCER GENETICS, INC (Filer) CIK: 0001349929 (see all company filings)

IRS No.: 043462475 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35817 | Film No.: 18958607
SIC: 8071 Services-Medical Laboratories
Assistant Director 9